biology-technology-1/virtify--inc--delivers-industrys-first-enterprise-content-compliance-software-suite-for-life-sciences-companies-12722-1/;msg90356

(Date:12/7/2009)... NY) Matthew Levy, Ph.D., assistant professor of ... Yeshiva University, has been awarded more than $700,000 ... high-risk/high-reward cancer research. Dr. Levy,s work will focus ... cells, thus eliminating or significantly reducing serious or ... is one of 13 young scientists nationwide selected ...

(Date:12/6/2009)... York, N.Y./Los Angeles, Calif.: Stand Up To Cancer ... to support high-risk/high-reward cancer research conducted by 13 young ... a total of up to $750,000 as part of ... generation of cancer research leaders. , "We asked our ... comfort zones and strive to make big differences with ...

(Date:12/6/2009)... Just three months after the Euro 5 Norm for ... models, researchers at the Technische Universitaet Muenchen (TUM) have ... the more stringent Euro 6 emissions standard. A research ... of Internal Combustion Engines has succeeded in reducing the ... TUM engineers have also developed a probe that allows ...

(Date:12/6/2009)... has become a mainstay of multiple myeloma treatment ... system of patients who have received stem cell ... early clinical trial results to be presented by ... American Society of Hematology,s (ASH) annual meeting on ... Convention Center, Room 243-245, 5:45 pm CT). , ...

(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...

(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...

(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...

(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...

Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...

... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of Human MSY2/YBOX2. (Note: the ... (Peptide available as ...

Request Info...

Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...

... Triad Skull Clamp, compatible with the full ... of clamping force on all three skull ... the possibility of adjusting the force on ... be increased or decreased by adjusting the ...

A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....

... PocketChem UA is the first ... take up valuable lab bench space. ... the variability in results between operators ... on every run, corrects for ambient ...

... sensor catheters incorporate a lumen ... wire, or high-speed injection/guide wire. ... injection has two laterally opposed ... open-end pigtail extension for use ...